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twenty patients given needle acupuncture sessions by a rate same as 
laser group and group C (control group) under their asthmatic medica-
tions only. Assessing of the clinical condition of the patient (frequency 
of attack and severity of asthma) and laboratory (IgE level and Eosino-
phil count) before and after the study.
Results: Frequency of asthmatic attack diminished in group A 
(p  <  0.001) more than in group B (p  =  0.002) and least in group C 
(p =  0.147) at the end of the study, Clinical severity of group A sig-
nificantly improved (p  <  0.001) than group B and C, IgE level were 
significantly improved in both groups A and B (p < 0.001) better than 
changes occurred in group C (p = 0.057). Eosinophilic count showed 
more significantly improvement in group A (p < 0.001) than group B 
(p = 0.206) and group C (p = 0.784).
Conclusions: Application of laser acupuncture sessions beside medi-
cal treatment results in more significantly improvement of the asthma 
frequency of attack, the degree of asthma severity, IgE level and eosin-
ophilic count in asthmatic children than the use of needle acupunc-
ture or medications used only.
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Introduction: The exhaled carbon monoxide is an important bio-
marker of the oxidative stress and the airways inflammation. Most 
scientific publications account of increase values in asthma. How-
ever our known literature does not have data on the relationship 
between different stadiums of asthma control and the exhaled 
carbon monoxide values. The aim of this study was to access this 
correlation.
Method: Our patients are well controlled, partly and uncontrolled 
asthma bronchial children, who are treated in outpatient clinic. Each 
of them has treatment according to GINA protocol. Before spirometry, 
patients were made deep inhalation, then they were made slow exha-
lation to the carbon monoxide measure equipment. (PiCO + Smoker-
lyzer) The exhaled carbon monoxide values were only known by the 
assistant, so that these values wouldn’t influence when putting in a cat-
egory. We made the statistic by InStat softver. We used non-parametric 
procedures.
Results: We found significant differences between the groups of well 
controlled and group of partly or uncontrolled in concentration of 
exhaled carbon monoxide, but significant difference was not demon-
strable between the group of partly controlled and group of uncon-
trolled (Table 1).
Conclusion: According to our investigation/examinations the 
exhaled carbon monoxide is significantly higher in partly or uncon-
trolled stadium of asthma bronchial than in well controlled stadium 
of asthma. This higher amount of exhaled carbon monoxide values 
show the raising of airways inflammation and the finish of well con-
trolled stadium. The exhaled carbon monoxide suggests the inflam-
mation aspect of asthma bronchial. Detailed analysis of our results 
shows that the eCO can be used to estimate the compliance of 
patients (Table 2).
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Importance: Observational studies have suggested that increased 
dietary Vitamin D intake during pregnancy may protect the offspring 
against preschool wheezing, which is the most common disorder in 
young children.
Objective: To determine whether supplementation of Vitamin D3 dur-
ing third trimester of pregnancy reduces the risk of persistent wheeze 
in the offspring.
Design, setting and participants: The study was a double-blinded, 
single-center, randomized controlled trial conducted within the 
Copenhagen Prospective Study on Asthma in Childhood (COPSAC2010) 
unselected mother–child cohort. A total of 627 women were recruited 
for the Vitamin D trial at 24 weeks of pregnancy, between March 4th 
2009 and November 17th 2010. Clinical follow-up of the children 
(n = 581) was completed when the youngest child turned 3 years and 
unblinded on March 28th 2014.
Intervention: Vitamin D3 (2400 IU/day) supplementation or matching 
placebo tablets from pregnancy week 24 to 1 week postpartum.
Main outcome measure: Persistent wheeze at age 0–5  years diag-
nosed solely by the intervention-blinded study pediatricians strictly 
adherent to a predefined algorithm based on 11 scheduled and addi-
tional acute clinic visits and a day-to-day symptom diary filled by the 
parents from birth. Secondary outcomes were number of wheezy epi-
sodes, asthma, neonatal airway immunology, respiratory infections, 
allergic sensitization and eczema.
Results: Occurrence of persistent wheeze did not differ between the 
Vitamin D3 supplement and control group (incidence, 18 % vs. 21 %; 
hazard ratio, 0.79; 95 % CI, 0.54–1.14, P = 0.21). The number of wheezy 
episodes was reduced by the Vitamin D3 intervention (mean 5.9 vs. 7.2 
episodes; incidence risk ratio, 0.83; 95  % CI, 0.71–0.97, P =  0.02) and 
the airway immune profile at age one month was up-regulated (prin-
ciple component analysis, P = 0.04). There was no effect on additional 
end-points.
Conclusion: The use of Vitamin D3 supplementation during pregnancy 
did not reduce the risk of persistent wheeze in the offspring.
Table 1 Summary
Well  
controlled
Partly  
controlled
Uncontrolled Significance
Number of 
patients
99 (37 %) 102 (38 %) 68 (25 %)
eCO (ppm) 3.21 (SD: 
1.15)
4.88 (SD: 
2.60)
5.55 (SD: 2.49) P < 0.0001
Table 2 Summary
Controlled Partly 
controlled
Uncontrolled Significant 
relation
Patients 
number 
(male/
female)
99 (37 %) 
(51/48)
102 (38 %) 
(62/40)
68 (25 %) 
(36/32)
–
Age 11.13 11.23 10.97 p > 0.05
FVC% 94.53 94.06 94.74 p > 0.05
FEV1% 95.29 92.24 91.57 p > 0.05
FEV1/FVC 88.24 85.68 85.41 P < 0.05 
(p = 0.0186)
FEF25–75 % 94.82 85.95 86.65 P < 0.05 
(p = 0.0163)
eCO/ppm/ 3.21 4.88 5.55 P < 0.05 
(p < 0.0001)
